DrugPatentWatch Database Preview
Profile for Canada Patent: 2603740
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2603740
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 5, 2026 | Glaxosmithkline Cons | FLONASE SENSIMIST ALLERGY RELIEF | fluticasone furoate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |